KardiaMobile® 6L: Medical-grade ECGs in 30 seconds with QT measurements

Whenever you need heart rate and rhythm information, KardiaMobile 6L helps you get the clarity you need quickly and easily. With wide-ranging use cases from detecting atrial fibrillation to monitoring QT in clinical research and beyond, KardiaMobile 6L is trusted by leading cardiologists, top biopharma companies, large CROs, Fortune 100 employers, and major healthcare systems.

KardiaMobile® 6L

The first FDA-cleared, 6-lead personal ECG device.

Easier for Patients. Insightful for Clinicians.

In just 30 seconds, KardiaMobile 6L provides access to a high-quality, 6-lead ECG without the hassle of wires, patches, or gels – making it easy for patients in the home or the office.

Ideal for capturing a quick ECG at an office visit or for extended remote monitoring, the easy-to-use KardiaMobile 6L provides flexibility to diagnose and treat patients.

Faster Insights

  • Captures a 6-lead, medical-grade ECG in 30 seconds
  • Clear view of P, QRS, and T waves to identify atrial fibrillation, atrial flutter, and heart block
  • FDA-cleared Kardia AI detects 6 of the most common arrhythmias
    – Atrial Fibrillation
    – Bradycardia
    – Tachycardia
    – Sinus Rhythm with PVCs
    – Sinus Rhythm with Wide QRS
    – Sinus Rhythm with SVE

Easier ECG Process

  • No patient prep time or adhesives neede
  • Compatible with most smartphones and tablets. See compatibility chart.
  • Streamlined, secure data flow through KardiaPro web-based portal.
  • Integration options available with SDK, API, and leading EHR platforms – including GE HealthCare’s MUSE™ NX and Epic App Orchard. Learn more about Data Integration options.

Streamlined QT Interval Monitoring

  • Accurate QT measurements with FDA-cleared algorithm
  • In-office or remote monitoring options
  • Screens for acquired long QT

KardiaMobile® 6L

The first FDA-cleared, 6-lead personal ECG device.

Easier for Patients. Insightful for Clinicians.

In just 30 seconds, KardiaMobile 6L provides access to a high-quality, 6-lead ECG without the hassle of wires, patches, or gels – making it easy for patients in the home or the office.

Ideal for capturing a quick ECG at an office visit or for extended remote monitoring, the easy-to-use KardiaMobile 6L provides flexibility to diagnose and treat patients.

Faster Insights

  • Captures a 6-lead, medical-grade ECG in 30 seconds
  • Clear view of P, QRS, and T waves to identify atrial fibrillation, atrial flutter, and heart block
  • FDA-cleared Kardia AI detects 6 of the most common arrhythmias
    – Atrial Fibrillation
    – Bradycardia
    – Tachycardia
    – Sinus Rhythm with PVCs
    – Sinus Rhythm with Wide QRS
    – Sinus Rhythm with SVE

Easier ECG Process

  • No patient prep time or adhesives neede
  • Compatible with most smartphones and tablets. See compatibility chart.
  • Streamlined, secure data flow through KardiaPro web-based portal.
  • Integration options available with SDK, API, and leading EHR platforms – including GE HealthCare’s MUSE™ NX and Epic App Orchard. Learn more about Data Integration options.

Streamlined QT Interval Monitoring

  • Accurate QT measurements with FDA-cleared algorithm
  • In-office or remote monitoring options
  • Screens for acquired long QT

Explore our solutions from hospital to home, powered by KardiaMobile 6L

KardiaStation™ App

 

Designed for clinicians to record and view ECGs efficiently at point-of-care. Triage patients in minutes with a HIPAA-compliant, SOC-2 certified system.

KardiaRx App

 

Designed for patients and clinical trial participants to record ECGs easily from home. Data are securely and automatically transmitted, enabling timely professional review of rate and rhythm information.

Trusted results that help you treat with confidence

he world’s leading cardiologists use KardiaMobile, the most clinically validated personal ECG brand with over 185 clinical publications. Learn how KardiaMobile 6L can help you better treat your patients.

Atrial Fibrillation

Confidently prescribe QT-prolonging medication

Streamline QT interval monitoring with an accurate measurement in only 30 seconds for QT-prolonging medications.

READ MORE

Hassle-free for patients

KardiaMoblie 6L was used post-TAVR with consecutive patients to monitor for delayed conduction disease in an elderly population (average age 81.8) for one month.1 Patients were trained on the device and submitted ECGs daily for the 1st week and weekly thereafter.

READ MORE

Demonstrated higher accuracy than single-lead smartwatches6

Study findings suggest that KardiaMobile 6L provides a clinical benefit with higher accuracy compared to single-lead smartwatch devices when reviewed by a cardiologist.

READ MORE
““I am impressed with the quality and simplicity of 6-lead smartphone ECG tracings which will unquestionably sharpen our ability to diagnose heart rhythm and conduction abnormalities.””
ERIC TOPOL, MD, CARDIOLOGIST

Founder and Director Scripps Research Translational Institute, and author of the new book, Deep Medicine

Dr. Topol has no financial relationship with or research support from AliveCor.

Atrial Fibrillation

Confidently prescribe QT-prolonging medication

Streamline QT interval monitoring with an accurate measurement in only 30 seconds for QT-prolonging medications.

Hassle-free for patients

KardiaMoblie 6L was used post-TAVR with consecutive patients to monitor for delayed conduction disease in an elderly population (average age 81.8) for one month.1 Patients were trained on the device and submitted ECGs daily for the 1st week and weekly thereafter.

READ MORE

Demonstrated higher accuracy than single-lead smartwatches6

Study findings suggest that KardiaMobile 6L provides a clinical benefit with higher accuracy compared to single-lead smartwatch devices when reviewed by a cardiologist.

READ MORE
““I am impressed with the quality and simplicity of 6-lead smartphone ECG tracings which will unquestionably sharpen our ability to diagnose heart rhythm and conduction abnormalities.””
ERIC TOPOL, MD, CARDIOLOGIST

Founder and Director Scripps Research Translational Institute, and author of the new book, Deep Medicine

Dr. Topol has no financial relationship with or research support from AliveCor.

 

Explore how AliveCor’s digital health solutions can transform cardiovascular care.

 

Explore how AliveCor’s digital health solutions can transform cardiovascular care.

CONTACT US

Legal

KardiaMobile 6L is not tested or recommended for use with pacemakers and ICDs. KardiaMobile 6L does not check for heart attack.

For compatibility information, visit alivecor.com/compatibility.

1. De Lucia R, et al. Europace (2023) 25, 116-1125.
2. Wong KC et al. Heart. 2020 Aug;106(16):1211-1217.
3. Halcox, JPJ et al. Circulation vol. 136,19 (2017): 1784-1794.
4. Woosley RL, Heise CW, Gallo T, Woosley D and Romero KA, www.CredibleMeds.org, QTdrugs List, September 13, 2023
5. JR et al. Circulation. 2021 Mar 30;143(13):1274-1286.
6. Scholten J et al. Am Heart J. 2022 Nov;253:53-58.